Verve Therapeutics
Joseph DePeter is a Senior Engineer, Process Development at Verve Therapeutics, with over five years of experience in the manufacturing and development of mRNA therapeutics. Prior to joining Verve, Joe worked at Laronde, where he researched and developed separation techniques for novel nucleic acid therapies. Previously, he established a clinical scale mRNA purification process at Intellia Therapeutics. He received his B.S. in chemical engineering from Northeastern University.
This person is not in any offices
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.